Detection and quantification of multiple proteins in biological fluids and tissues is of fundamental importance in biomedical research and clinical diagnostics because it is impossible to understand complex, non-linear, biochemical systems without being able to accurately interrogate the components. The need to interrogate multiple proteins simultaneously is ubiquitous across all domains of biomedical research, and it is a major barrier to fully understanding health, ageing, disease, and response to therapeutic interventions. Though the need may be ubiquitous, there is not a widely accessible solution for researchers to make multiplexed protein measurement with high sensitivity and a large dynamic range. Antibody microarrays have a straightforward, ELISA-like workflow and can be used to measure up to thousands of proteins simultaneously. Unfortunately, they have rather poor sensitivity, and require a specialized and expensive (>$75k) reader to be used. These are significant barriers to adoption for the majority of biomedical researchers. We have developed an ultrabright fluorescent nanoconstruct we call the Plasmonic Fluor, which is >5,000X brighter than the standard fluorescent reporter used in microarrays today. Simply substituting the Plasmonic Fluor for the existing reporter significantly increases the sensitivity of antibody microarrays without requiring any change to the workflow. Importantly, the Plasmonic Fluor is so bright that it allows fluorescent microarrays to be read using more widely available and versatile readers such as a fluorescent Western blot reader. Additionally, it relaxes the requirements on the reader instrumentation significantly, which has enabled us to create an inexpensive reader that any research lab can afford. To allow even easier adoption of the Plasmonic Fluor enhanced microarrays, we have also created software for microarray data analysis. In this project, we aim to: increase the manufacturing scale of our Plasmonic Fluor to an early commercial scale; more extensively validate enhancement of a variety of popular antibody microarrays; finalize the design of our inexpensive reader; and more fully develop our user- friendly microarray analysis software. We believe the Plasmonic Fluor will become the standard fluorescent reporter molecule for all microarrays, and Plasmonic Fluor-enhanced microarrays will become a widely used and powerful tool for elucidating the role of protein networks in health and disease.
Public Health Relevance Statement: Project Narrative There is a significant need in biomedical research for a widely available tool which can be used to simultaneously measure multiple proteins in biological samples with high sensitivity. We have developed an ultrabright fluorescent nanoconstruct we call a Plasmonic Fluor that can significantly improve an existing assay known as antibody microarrays without any change to the workflow. Importantly, the Plasmonic Fluor is so bright that it allows these assays to be read on more widely available readers or even a very inexpensive reader we have developed, and this will enable will enable more biomedical researchers to use these powerful assays to better understand health and disease.
Project Terms: Adoption; Aging; Antibodies; Biological Assay; Assay; Bioassay; Biologic Assays; Biomedical Research; Western Blotting; Western Immunoblotting; protein blotting; Malignant Neoplasms; Cancers; Malignant Tumor; malignancy; neoplasm/cancer; Capital; Clinical Research; Clinical Study; Data Analyses; Data Analysis; data interpretation; Disease; Disorder; Elements; Enzyme-Linked Immunosorbent Assay; ELISA; Equipment; Fluorescence; Freeze Drying; Freeze Dryings; Lyophilization; Glass; Goals; Health; Immunoassay; instrumentation; Laboratory Research; Lasers; Laser Electromagnetic; Laser Radiation; Light; Photoradiation; Methods; Proteins; Reading; Research; research and development; Development and Research; R & D; R&D; Research Personnel; Investigators; Researchers; Role; social role; Signal Transduction; Cell Communication and Signaling; Cell Signaling; Intracellular Communication and Signaling; Signal Transduction Systems; Signaling; biological signal transduction; Computer software; Software; Testing; Tissues; Body Tissues; Translations; Work; Streptavidin; Strepavidin; cytokine; Measures; Price; pricing; Sapphire; base; Label; improved; Procedures; Biological; Biochemical; Ensure; Measurement; fluid; liquid; Liquid substance; Reporter; tool; Life; programs; Complex; Protocol; Protocols documentation; Source; System; Degenerative Neurologic Diseases; Degenerative Neurologic Disorders; Nervous System Degenerative Diseases; Neural Degenerative Diseases; Neural degenerative Disorders; Neurodegenerative Diseases; Neurologic Degenerative Conditions; degenerative diseases of motor and sensory neurons; degenerative neurological diseases; neurodegenerative illness; Neurodegenerative Disorders; Performance; fluorophore; Cellulose Nitrate; Nitrocellulose; Pyroxylin; Proteome; intervention therapy; Therapeutic Intervention; Sampling; response; Proteomics; Microarray-Based Analysis; microarray analyses; microarray technology; Microarray Analysis; Detection; Protein Analysis; Reader; imaging; Image; cost; designing; design; user-friendly; prototype; bio-markers; biologic marker; biomarker; Biological Markers; complex biological systems; plasmonics; clinical diagnostics
